Kyle R Crassini (Kyle Crassini)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Chronic Lymphocytic Leukemia

Top Venues

British journal of haematology

Internal medicine journal

This page only lists publications with an associated author ORCID identifier.

Publications

Kyle R Crassini, John Gibson
Pathogenesis and management of immune dysfunction secondary to B cell haematological malignancies. Internal medicine journal (2023)
Narjis Fatima, Yandong Shen, Kyle R Crassini, Edwin J Iwanowicz, Henk Lang, Donald S Karanewsky, Richard I Christopherson, Stephen P Mulligan, Oliver Giles Best
The ClpP activator ONC-212 (TR-31) inhibits BCL2 and B-cell receptor signaling in CLL. EJHaem 2 (1) (2021)
Kyle R Crassini, William S Stevenson, Stephen P Mulligan, Oliver Giles Best
Molecular pathogenesis of chronic lymphocytic leukaemia. British journal of haematology 186 (5) (2019)
Kyle R Crassini, Eva Zhang, Shalini Balendran, Jane A Freeman, O Giles Best, Cecily J Forsyth, Naomi J Mackinlay, Ping Han, William S Stevenson, Stephen P Mulligan
Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment-free and overall survival in Chronic Lymphocytic Leukaemia. British journal of haematology 181 (1) (2018)
Kyle R Crassini, Yandong Shen, Michael O'Dwyer, Michael O'Neill, Richard Christopherson, Stephen Mulligan, Oliver Giles Best
The dual inhibitor of the phosphoinositol-3 and PIM kinases, IBL-202, is effective against chronic lymphocytic leukaemia cells under conditions that mimic the hypoxic tumour microenvironment. British journal of haematology 182 (5) (2018)
Kyle R Crassini, Yandong Shen, William S Stevenson, Richard Christopherson, Chris Ward, Stephen P Mulligan, Oliver Giles Best
MEK1/2 inhibition by binimetinib is effective as a single agent and potentiates the actions of Venetoclax and ABT-737 under conditions that mimic the chronic lymphocytic leukaemia (CLL) tumour microenvironment. British journal of haematology 182 (3) (2018)